Could a new drug tame fatty liver disease? early trial aims to find out
NCT ID NCT05945537
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This early-stage trial is testing an experimental drug called INI-822 to see if it is safe and tolerable. It involves healthy volunteers and people with MASH, a type of fatty liver disease. The study will give different doses of the drug or a placebo to see how the body handles it and whether it causes any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- INI-822
- What this could lead to
- If successful, this could lead to a new treatment option for MASH, a common liver disease with no approved therapies.
- What could go wrong
- This is an early-stage trial focused on safety, not effectiveness. The drug may not work or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Box Hill Hospital, Level 1, 5 Arnold street
RECRUITINGBox Hill, Victoria, 3128, Australia
-
Campbelltown Hospital, Level 10, building A, Campbelltown Hospital, Therry Road,
NOT_YET_RECRUITINGCampbelltown, New South Wales (nsw), 2560, Australia
-
Flinders Medical Centre, Flinders Medical Centre, Flinders
RECRUITINGBedford Park, South Australia (SA), 5042, Australia
-
Genesis Research Services, Ground Floor, 239/245 Denison Street Broadmeadow
RECRUITINGNewcastle, New South Wales (nsw), 2292, Australia
-
Princess Alexandra Hospital
RECRUITINGWoolloongabba, Queensland, 4102, Australia
-
Ramsay Health North Shore, North Shore Private, 03 Westbourne Street
NOT_YET_RECRUITINGSaint Leonards, New South Wales (nsw), 2065, Australia
-
Royal Prince Alfred Hospital
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
St. Vincent's Hospital Melbourne
RECRUITINGFitzroy, Victoria, 3065, Australia
-
TrialsWest Pty Ltd, 90 Anstruther Road
RECRUITINGMandurah, Western Australia (WA), 6210, Australia
-
University of the Sunshine Coast Clinical Trials (Birtinya), UniSC Clinical Trials Vitality Village, Level 4, Tenancy 410, 5 Discovery Court
RECRUITINGBirtinya, Queensland (qld), 4575, Australia
-
Westmead Hospital, Storr Liver Centre, Level 2, A/B Block, Westmead Hospital Corner Hawkesbury and Darcy Roads
RECRUITINGWestmead, Westmead, 2145, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Weight-Loss surgery rewire the Liver's energy engine?
- Liver scan changes may foretell deadly complications
- Could a weekly shot help more people donate part of their liver?
- Experimental drug aims to reverse liver scarring in MASH cirrhosis
- Experimental drug aims to stop liver failure in MASH cirrhosis
- Could a fatty liver fuel Alzheimer's? new scan aims to find out